Finzati - Logo
MNOV logo

MediciNova, Inc.

MNOV • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$64.48M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 8.16Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:29 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$64.48M
52W Range1.17 - 1.96
Beta0.62
Gross Margin7.58%
Oper. Margin-32.42%
Profit Margin-29.29%
Debt/Eq0.00
Current Ratio8.16
Quick Ratio8.16
Volume21.99K

Investment DNA

How strong this company looks for long-term investors

35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
55/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 8.16Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 12/8/2006
Industry: Biotechnology
P/B i: 1.55
Debt / Equity i: 0.00
Operating Margin: -3242.47%
Net Margin: -2928.78%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.00
Current Ratio: 8.16
Quick Ratio: 8.16
Status: Good

Insider Transactions

Recent executive and insider activity

BEAVER CAROLYN
Transaction: 06/23/2026
BUY
Change
+44,500
Price
$1.36
Filing
06/25/2026
Type
BUY
Lemerond Nicole
Transaction: 06/23/2026
BUY
Change
+44,500
Price
$1.36
Filing
06/25/2026
Type
BUY
Nagao Hideki
Transaction: 06/23/2026
BUY
Change
+44,500
Price
$1.36
Filing
06/25/2026
Type
BUY